StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

CGONBullishAnalyst Target Updateanalyst
Medium materiality6/10

JPMorgan Raises CG Oncology Price Target to $113

Nov 17, 2026, 10:08 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The target implies substantial upside, though analyst targets are opinions and the sharp recent decline is a caution.

AI summary

What happened, with direct paths to the underlying reporting

JPMorgan raised its CGON target to $113, about 33% above the posted price of $84.78. Shares were down 9.88% since the signal, adding near-term volatility to the bullish target-based view.

  • JPMorgan raised its CGON target to $113, about 33% above the posted price.
  • CGON was down 9.88% since the signal.

Key facts

  1. 01

    Target: $113

  2. 02

    Posted price: $84.78

  3. 03

    Analyst firm: J.P. Morgan

  4. 04

    Analyst: Brian Cheng

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.